Deepika Jalota - Sep 15, 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Development Officer
Signature
/s/ Winston Kung, by power of attorney
Stock symbol
PMVP
Transactions as of
Sep 15, 2023
Transactions value $
-$27,168
Form type
4
Date filed
9/18/2023, 04:26 PM
Previous filing
May 15, 2023
Next filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale -$27.2K -4.1K -12.05% $6.62 29.9K Sep 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.